Cargando…

Recombinant human interleukin receptor antagonist influences serum chemokines in patients with rheumatoid arthritis

OBJECTIVE: To investigate the serum expressions of chemokines CCL2 and CCL3 in patients with rheumatoid arthritis (RA) who were treated with recombinant human interleukin 1 (IL-1) receptor antagonist (IL-1Ra). MATERIAL AND METHODS: Serum CCL2 and CCL3 were determined using an enzyme-linked immunosor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Jun, Liu, Wei, Bao, Yi-Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Society of Experimental and Clinical Immunology 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440034/ https://www.ncbi.nlm.nih.gov/pubmed/26155119 http://dx.doi.org/10.5114/ceji.2014.43717

Ejemplares similares

Chemokines and chemokine receptors as promising targets in rheumatoid arthritis
por: Murayama, Masanori A., et al.
Publicado: (2023)

Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis
por: Elemam, Noha Mousaad, et al.
Publicado: (2020)

The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis
por: Ismail, Endom, et al.
Publicado: (2016)

Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis
por: Li, Songsong, et al.
Publicado: (2016)

Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

Chemokines in Rheumatoid Arthritis
por: Koch, Alisa
Publicado: (2000)

Homing chemokines in rheumatoid arthritis
por: Loetscher, Pius, et al.
Publicado: (2002)

Development of Chronic Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Interleukin 1 Receptor Antagonist–Deficient Mice
por: Horai, Reiko, et al.
Publicado: (2000)

MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in Rheumatoid Arthritis
por: Elmesmari, Aziza, et al.
Publicado: (2016)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
por: Robak, T, et al.
Publicado: (1998)

Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis
por: Nanki, Toshihiro, et al.
Publicado: (2009)

Effects of leukotriene B4 on interleukin-32, interferon-γ and chemokines in rats with rheumatoid arthritis
por: Bi, Danyan, et al.
Publicado: (2017)

Expression of chemokines and their receptors in synovial tissue of patients with rheumatoid arthritis, osteoarthritis and reactive arthritis
por: Haringman, JJ, et al.
Publicado: (2003)

Interleukin-1 Receptor Antagonist Isoforms in Collagen-Induced Arthritis
por: Gabay, Cem, et al.
Publicado: (2000)

Chemokines in rheumatoid arthritis: novel, potential therapeutic targets of the CCR2 chemokine receptor signaling pathway
por: Matsushima, K, et al.
Publicado: (2003)

Interleukin-6 receptor in the recent-onset rheumatoid arthritis
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2011)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Healthy Chinese Subjects
por: Xie, Ran, et al.
Publicado: (2018)

Targeting the Chemokine System in Rheumatoid Arthritis and Vasculitis
por: Miyabe, Yoshishige, et al.
Publicado: (2020)

Role of interleukin-25 in development of spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice
por: Abe, Yasuharu, et al.
Publicado: (2017)

Interleukin 6 and Rheumatoid Arthritis
por: Yoshida, Yuji, et al.
Publicado: (2014)

Interleukin-6 in Rheumatoid Arthritis
por: Pandolfi, Franco, et al.
Publicado: (2020)

The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse
por: Bjrök, P., et al.
Publicado: (1992)

Genetic association between interleukin-17 and susceptibility to rheumatoid arthritis
por: Zhao, Rong, et al.
Publicado: (2023)

Screening of chemokine receptor CCR4 antagonists by capillary zone electrophoresis
por: Sun, Zhe, et al.
Publicado: (2011)

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice
Publicado: (1991)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
por: Mihara, Masahiko, et al.
Publicado: (2011)

A peptoid interleukin‐15 receptor antagonist suppresses inflammation and arthritis in mice
por: Cho, Kwang Bog, et al.
Publicado: (2022)

Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis
por: Xin, Pan Lin, et al.
Publicado: (2021)

Chemokine Signaling Pathway Involved in CCL2 Expression in Patients with Rheumatoid Arthritis
por: Zhang, Lin, et al.
Publicado: (2015)

Serum interleukin-6 in seropositive rheumatoid arthritis and response to tocilizumab: An observational study
por: Kumar, Abhishek, et al.
Publicado: (2022)

Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial
por: Fleishaker, Dona L, et al.
Publicado: (2012)

Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody
por: Yanagida, Mitsuaki, et al.
Publicado: (2013)

Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis
por: Hoffman, Elinoar, et al.
Publicado: (2019)

Interleukin-7 deficiency in rheumatoid arthritis
por: Leonard, Warren J
Publicado: (2005)

Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels
por: Jones, Jonathan D, et al.
Publicado: (2014)

Proinflammatory Soluble Interleukin-15 Receptor Alpha Is Increased in Rheumatoid Arthritis
por: Machado Diaz, Ana Cecilia, et al.
Publicado: (2012)

Pretreatment Prediction of Individual Rheumatoid Arthritis Patients’ Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers
por: Uno, Kazuko, et al.
Publicado: (2015)

Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist
por: Tsai, Ming-Ling, et al.
Publicado: (2009)

Chemokine blockade: a new era in the treatment of rheumatoid arthritis?
por: Haringman, Jasper J, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_gemitkl4k7o1svns2ii2j6s6ik